Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
Main Authors: | Markos Marangos, Anastasia Parthymou, Evagelia E Habeos, George I Habeos, Apostolos Deligakis, Ektoras Livieratos, Dionysios V Chartoumpekis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-05-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/5/e057084.full |
Similar Items
-
Persistence of Anti-S Titre among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19
by: Luca Coppeta, et al.
Published: (2021-08-01) -
Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine
by: Yushi Nomura, et al.
Published: (2021-09-01) -
Maternal Calorie Restriction Induces a Transcriptional Cytoprotective Response in Embryonic Liver Partially Dependent on Nrf2
by: George I. Habeos, et al.
Published: (2022-11-01) -
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
by: Rieke Reiter, et al.
Published: (2022-05-01) -
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
by: Xin Rong Lim, et al.
Published: (2021-08-01)